These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8803774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.
    Gibson KM, Jakobs C, Ogier H, Hagenfeldt L, Eeg-Olofsson KE, Eeg-Olofsson O, Aksu F, Weber HP, Rossier E, Vollmer B.
    J Inherit Metab Dis; 1995; 18(2):143-6. PubMed ID: 7564230
    [No Abstract] [Full Text] [Related]

  • 3. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.
    Gropman A.
    Ann Neurol; 2003; 54 Suppl 6():S66-72. PubMed ID: 12891656
    [Abstract] [Full Text] [Related]

  • 4. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.
    Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G, Raab K, Kobori J, Moosa A, Vollmer B, Rossier E, Iafolla AK, Matern D, Brouwer OF, Finkelstein J, Aksu F, Weber HP, Bakkeren JA, Gabreels FJ, Bluestone D, Barron TF, Beauvais P, Rabier D, Santos C, Lehnert W.
    Pediatrics; 1997 Apr; 99(4):567-74. PubMed ID: 9093300
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
    Gupta M, Greven R, Jansen EE, Jakobs C, Hogema BM, Froestl W, Snead OC, Bartels H, Grompe M, Gibson KM.
    J Pharmacol Exp Ther; 2002 Jul; 302(1):180-7. PubMed ID: 12065715
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. GABA shunt deficiencies and accumulation of reactive oxygen intermediates: insight from Arabidopsis mutants.
    Fait A, Yellin A, Fromm H.
    FEBS Lett; 2005 Jan 17; 579(2):415-20. PubMed ID: 15642352
    [Abstract] [Full Text] [Related]

  • 8. Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria).
    Gordon N.
    Eur J Paediatr Neurol; 2004 Jan 17; 8(5):261-5. PubMed ID: 15341910
    [Abstract] [Full Text] [Related]

  • 9. Inherited disorders of GABA metabolism.
    Jakobs C, Jaeken J, Gibson KM.
    J Inherit Metab Dis; 1993 Jan 17; 16(4):704-15. PubMed ID: 8412016
    [Abstract] [Full Text] [Related]

  • 10. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.
    Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C.
    Neuropediatrics; 1998 Feb 17; 29(1):14-22. PubMed ID: 9553943
    [Abstract] [Full Text] [Related]

  • 11. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.
    Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, Tuchman M.
    Neurology; 2003 May 13; 60(9):1413-7. PubMed ID: 12743223
    [Abstract] [Full Text] [Related]

  • 12.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Pearl PL, Wiwattanadittakul N, Roullet JB, Gibson KM.
    ; 1993 May 13. PubMed ID: 20301374
    [Abstract] [Full Text] [Related]

  • 13. Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.
    Jakobs C, Michael T, Jaeger E, Jaeken J, Gibson KM.
    Eur J Pediatr; 1992 Jun 13; 151(6):466. PubMed ID: 1628679
    [No Abstract] [Full Text] [Related]

  • 14. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A, Ordovás Baines JP, Beltrán Marqués M, Escrivá Aparisi A, Delgado Cordón F.
    Ann Pharmacother; 1995 Nov 13; 29(11):1115-7. PubMed ID: 8573955
    [Abstract] [Full Text] [Related]

  • 15. Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation.
    Ravasz D, Kacso G, Fodor V, Horvath K, Adam-Vizi V, Chinopoulos C.
    Neurochem Int; 2017 Oct 13; 109():41-53. PubMed ID: 28300620
    [Abstract] [Full Text] [Related]

  • 16. Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.
    Cortez MA, Wu Y, Gibson KM, Snead OC.
    Pharmacol Biochem Behav; 2004 Nov 13; 79(3):547-53. PubMed ID: 15582027
    [Abstract] [Full Text] [Related]

  • 17. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.
    Ethofer T, Seeger U, Klose U, Erb M, Kardatzki B, Kraft E, Landwehrmeyer GB, Grodd W, Storch A.
    Neurology; 2004 Mar 23; 62(6):1016-8. PubMed ID: 15037717
    [Abstract] [Full Text] [Related]

  • 18. Status epilepticus during vigabatrin treatment: a report of three cases.
    de Krom MC, Verduin N, Visser E, Kleijer M, Scholtes F, De Groen JH.
    Seizure; 1995 Jun 23; 4(2):159-62. PubMed ID: 7670770
    [Abstract] [Full Text] [Related]

  • 19. Clinical aspects of the disorders of GABA metabolism in children.
    Pearl PL, Gibson KM.
    Curr Opin Neurol; 2004 Apr 23; 17(2):107-13. PubMed ID: 15021235
    [Abstract] [Full Text] [Related]

  • 20. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).
    Manor D, Rothman DL, Mason GF, Hyder F, Petroff OA, Behar KL.
    Neurochem Res; 1996 Sep 23; 21(9):1031-41. PubMed ID: 8897466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.